Veerhealth Care Ltd
₹ 14.0
1.97%
23 May
11:02 a.m.
About
Incorporated in 1992, Veer Healthcare Ltd (formerly Niyati Leasing Ltd) is engaged in
the business of trading and manufacturing and marketing research based ayurvedic medicines
Key Points
- Market Cap ₹ 28.0 Cr.
- Current Price ₹ 14.0
- High / Low ₹ 27.0 / 9.29
- Stock P/E
- Book Value ₹ 11.1
- Dividend Yield 0.00 %
- ROCE 5.96 %
- ROE 1.90 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 31.5%
- Company has a low return on equity of 3.60% over last 3 years.
- Earnings include an other income of Rs.0.96 Cr.
- Debtor days have increased from 72.4 to 108 days.
- Promoter holding has decreased over last 3 years: -10.8%
- Working capital days have increased from 191 days to 289 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Upcoming result date: 30 May 2025
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.16 | 3.52 | 1.33 | 2.14 | 1.89 | 5.17 | 5.98 | 11.72 | 10.62 | 9.64 | 13.28 | 13.22 | 14.42 | |
| 3.14 | 3.47 | 1.48 | 2.16 | 2.25 | 5.29 | 5.54 | 11.04 | 10.56 | 10.46 | 12.78 | 12.61 | 13.64 | |
| Operating Profit | 0.02 | 0.05 | -0.15 | -0.02 | -0.36 | -0.12 | 0.44 | 0.68 | 0.06 | -0.82 | 0.50 | 0.61 | 0.78 |
| OPM % | 0.63% | 1.42% | -11.28% | -0.93% | -19.05% | -2.32% | 7.36% | 5.80% | 0.56% | -8.51% | 3.77% | 4.61% | 5.41% |
| -0.00 | 0.01 | 0.48 | 0.38 | 0.72 | 0.72 | 0.29 | 0.48 | 1.20 | 1.67 | 1.24 | 1.39 | 0.96 | |
| Interest | -0.00 | -0.00 | 0.06 | 0.13 | 0.10 | 0.07 | 0.03 | 0.19 | 0.22 | 0.09 | -0.00 | 0.01 | 0.12 |
| Depreciation | 0.02 | 0.02 | 0.11 | 0.21 | 0.23 | 0.27 | 0.32 | 0.32 | 0.47 | 0.52 | 0.62 | 0.71 | 0.82 |
| Profit before tax | -0.00 | 0.04 | 0.16 | 0.02 | 0.03 | 0.26 | 0.38 | 0.65 | 0.57 | 0.24 | 1.12 | 1.28 | 0.80 |
| Tax % | 25.00% | 62.50% | 100.00% | 33.33% | 42.31% | 57.89% | 50.77% | 35.09% | 129.17% | -41.07% | 68.75% | ||
| 0.01 | 0.03 | 0.06 | 0.01 | 0.02 | 0.14 | 0.16 | 0.32 | 0.38 | -0.07 | 1.58 | 0.41 | -0.06 | |
| EPS in Rs | 0.01 | 0.02 | 0.04 | 0.01 | 0.01 | 0.10 | 0.12 | 0.23 | 0.27 | -0.05 | 0.79 | 0.21 | -0.03 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 8% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 21% |
| 3 Years: | 3% |
| TTM: | -103% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 37% |
| 3 Years: | 34% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | 4% |
| Last Year: | 2% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.90 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 10.00 | 20.00 | 20.00 |
| Reserves | 5.85 | 5.81 | 5.86 | 5.88 | 5.92 | 6.17 | 6.35 | 6.82 | 7.11 | 7.02 | 11.43 | 1.84 | 2.26 |
| -0.00 | -0.00 | 1.01 | 1.08 | -0.17 | 1.21 | 0.94 | 2.48 | 1.73 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 1.73 | 0.18 | 0.24 | 0.23 | 0.37 | 0.42 | 1.94 | 1.76 | 2.96 | 6.20 | 3.82 | 6.28 | 8.71 | |
| Total Liabilities | 14.48 | 12.92 | 14.04 | 14.12 | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 30.97 |
| 0.15 | 4.90 | 2.07 | 2.71 | 2.52 | 5.54 | 5.46 | 9.45 | 9.48 | 10.54 | 12.01 | 11.97 | 14.81 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.24 | 2.19 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.31 |
| 14.32 | 8.02 | 11.97 | 11.41 | 10.53 | 8.95 | 8.51 | 8.54 | 9.25 | 9.61 | 13.24 | 16.15 | 15.85 | |
| Total Assets | 14.48 | 12.92 | 14.04 | 14.12 | 13.05 | 14.73 | 16.16 | 17.99 | 18.73 | 20.15 | 25.25 | 28.12 | 30.97 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.35 | 3.88 | -3.73 | -0.00 | 1.69 | 1.76 | 1.98 | -0.36 | 1.00 | 1.81 | -0.70 | 2.90 | |
| 7.58 | -4.26 | 3.85 | -0.01 | -0.44 | -3.02 | -1.90 | -1.67 | -0.09 | -1.09 | -1.79 | -0.28 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -1.33 | 1.31 | 0.02 | 1.85 | -0.83 | -0.42 | 5.69 | -5.99 | |
| Net Cash Flow | 0.23 | -0.38 | 0.12 | -0.01 | -0.08 | 0.06 | 0.10 | -0.17 | 0.09 | 0.30 | 3.21 | -3.37 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 197.52 | 8.30 | 255.23 | 151.80 | 117.80 | 64.95 | 45.17 | 29.27 | 52.93 | 58.31 | 50.57 | 108.23 |
| Inventory Days | 61.24 | 11.66 | 230.00 | 444.35 | 477.31 | 93.49 | 77.82 | 54.35 | 76.21 | 102.76 | 95.65 | 53.17 |
| Days Payable | 208.22 | 10.50 | 55.00 | 31.74 | 68.63 | 18.90 | 145.44 | 37.12 | 42.24 | 112.46 | 20.16 | 82.04 |
| Cash Conversion Cycle | 50.54 | 9.46 | 430.23 | 564.41 | 526.48 | 139.54 | -22.46 | 46.51 | 86.90 | 48.61 | 126.06 | 79.36 |
| Working Capital Days | 1,060.35 | 474.91 | 2,220.19 | 1,118.88 | 1,479.31 | 465.25 | 65.92 | 159.14 | 188.34 | 127.60 | 158.31 | 288.52 |
| ROCE % | -0.00% | 0.31% | -0.15% | 1.08% | 0.98% | 2.45% | 2.87% | 5.52% | 4.94% | 2.22% | 6.33% | 5.96% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
13h - Annual Secretarial Compliance Report for FY ended March 31, 2025; no violations or penalties reported.
-
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March, 2025 And Recommendation Of Dividend, If Any.
1d - Board meeting on May 30 to approve FY25 results and dividend; trading window reopens June 2.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - Veerhealth Care clears USFDA inspection, enabling $30-36 Cr annual US OTC exports and revenue growth.
-
Announcement Under Regulation 30 (LODR) - Successful Closure Of USFDA Inspection Under 21 CFR 20.64(D)(3)
16 May - USFDA inspection closed; Veerhealth qualified to export oral care products to USA.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Apr - DP) Regulations, 2018, please find attached herewith the certificate received from M/s. Purva Sharegistry (India) Private Limited, the Registrar and Share Transfer Agent of the …
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Sep 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
Feb 2024TranscriptPPT
Service Offered[1]
Contract Manufacturing, White Labelling, Product Development and Custom Formulation